Hyperthyroidism: Methimazole Plus L-carnitine and Selenium

Lo.Li.Pharma

Status: Completed

Conditions: Hyperthyroidism

Treatments: Dietary Supplement: L-carnitine+Selenium

Study type: Interventional

Funder types: Industry

Identifiers

NCT04946123

L-carnitine Hyperthyroidism

Details and patient eligibility

About

The study aims to investigate the benefits of methimazole treatment in patients with hyperthyroidism, associated with supplementation of L-carnitine and Selenium.

Enrollment: 60 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of hyperthyroidism requiring therapy with methimazole

Exclusion criteria

• Drug and alcohol abuse;
• Pregnancy;
• Medically uncontrolled psychiatric conditions;
• Interfering therapies (lithium, interferone, TKI, amiodarone)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

60 participants in 2 patient groups

methimazole (control)

No Intervention group

Description:

Patients with hyperthyroidism under methimazole treatment

methimazole+L-carnitine+selenium (intervention)

Experimental group

Description:

Patients with hyperthyroidism under methimazole treatment + supplementation with L-carnitine and Selenium

Treatment:

Dietary Supplement: L-carnitine+Selenium